Publicaciones en colaboración con investigadores/as de Ohio State University (18)

2020

  1. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients with Osteosarcoma

    JAMA Oncology, Vol. 6, Núm. 5, pp. 724-734

  2. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome

    Nature Cancer, Vol. 1, Núm. 11, pp. 1066-1081

2019

  1. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: Results from 3 UK clinical trials

    Blood Advances, Vol. 3, Núm. 16, pp. 2474-2481

2018

  1. Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients

    International Journal of Cancer, Vol. 142, Núm. 8, pp. 1594-1601

2016

  1. Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia

    Leukemia, Vol. 30, Núm. 11, pp. 2179-2186

  2. Immunodynamics: A cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials

    Journal for ImmunoTherapy of Cancer, Vol. 4, Núm. 1

  3. Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease

    Leukemia, Vol. 30, Núm. 6, pp. 1301-1310

2015

  1. A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma

    Cancer Discovery, Vol. 5, Núm. 9, pp. 920-931

  2. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  3. Germline TP53 Variants and Susceptibility to Osteosarcoma

    Journal of the National Cancer Institute, Vol. 107, Núm. 7

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2013

  1. Genome-wide association study identifies two susceptibility loci for osteosarcoma

    Nature Genetics, Vol. 45, Núm. 7, pp. 799-803

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine

1999

  1. Intraoperative high dose rate brachytherapy can be used to salvage patients with previously irradiated head and neck recurrences.

    Revista de medicina de la Universidad de Navarra, Vol. 43, Núm. 2, pp. 56-61

  2. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver

    Cancer, Vol. 85, Núm. 6, pp. 1218-1225

1998

  1. Interstitial brachytherapy in the management of primary carcinoma of the cervix and vagina

    Gynecologic Oncology, Vol. 70, Núm. 1, pp. 27-32

  2. Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies

    International Journal of Radiation Oncology Biology Physics, Vol. 42, Núm. 5, pp. 1085-1089

1997

  1. Pulmonary embolization of permanently implanted radioactive palladium- 103 seeds for carcinoma of the prostate

    International Journal of Radiation Oncology Biology Physics, Vol. 39, Núm. 3, pp. 667-670